93 related articles for article (PubMed ID: 11401963)
1. Interleukin-6 enhances production of anti-OspC immunoglobulin G2b borreliacidal antibody.
Remington MC; Munson EL; Callister SM; Molitor ML; Christopherson JA; DeCoster DJ; Lovrich SD; Schell RF
Infect Immun; 2001 Jul; 69(7):4268-75. PubMed ID: 11401963
[TBL] [Abstract][Full Text] [Related]
2. Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4.
Munson EL; Du Chateau BK; Jobe DA; Lovrich SD; Callister SM; Schell RF
Infect Immun; 2000 Oct; 68(10):5496-501. PubMed ID: 10992445
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro.
Munson EL; Nardelli DT; Luk KH; Remington MC; Callister SM; Schell RF
Clin Vaccine Immunol; 2006 Jan; 13(1):19-25. PubMed ID: 16425995
[TBL] [Abstract][Full Text] [Related]
4. Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.
Rousselle JC; Callister SM; Schell RF; Lovrich SD; Jobe DA; Marks JA; Wieneke CA
J Infect Dis; 1998 Sep; 178(3):733-41. PubMed ID: 9728542
[TBL] [Abstract][Full Text] [Related]
5. Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.
Ikushima M; Matsui K; Yamada F; Kawahashi S; Nishikawa SK
FEMS Immunol Med Microbiol; 2000 Sep; 29(1):15-21. PubMed ID: 10967255
[TBL] [Abstract][Full Text] [Related]
6. Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro.
Munson EL; Du Chateau BK; Jensen JR; Callister SM; DeCoster DJ; Schell RF
Clin Diagn Lab Immunol; 2002 Sep; 9(5):1095-101. PubMed ID: 12204965
[TBL] [Abstract][Full Text] [Related]
7. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
Lovrich SD; Jobe DA; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi.
Jensen JR; Du Chateau BK; Munson EL; Callister SM; Schell RF
Infect Immun; 1998 Apr; 66(4):1507-12. PubMed ID: 9529074
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine.
Padilla ML; Callister SM; Schell RF; Bryant GL; Jobe DA; Lovrich SD; DuChateau BK; Jensen JR
J Infect Dis; 1996 Oct; 174(4):739-46. PubMed ID: 8843211
[TBL] [Abstract][Full Text] [Related]
10. Role of IL-17, transforming growth factor-beta, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice.
Nardelli DT; Kevin Luk KH; Kotloski NJ; Warner TF; Torrealba JR; Callister SM; Schell RF
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):265-74. PubMed ID: 18522647
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice.
Munson EL; DeCoster DJ; Nardelli DT; England DM; Callister SM; Schell RF
Clin Diagn Lab Immunol; 2004 Jan; 11(1):35-41. PubMed ID: 14715542
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells.
Mbow ML; Zeidner N; Gilmore RD; Dolan M; Piesman J; Titus RG
Infect Immun; 2001 Apr; 69(4):2407-15. PubMed ID: 11254601
[TBL] [Abstract][Full Text] [Related]
13. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.
Jobe DA; Lovrich SD; Schell RF; Callister SM
Clin Diagn Lab Immunol; 2003 Jul; 10(4):573-8. PubMed ID: 12853388
[TBL] [Abstract][Full Text] [Related]
14. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.
Ma J; Bulger PA; Davis DR; Perilli-Palmer B; Bedore DA; Kensil CR; Young EM; Hung CH; Seals JR; Pavia CS
Vaccine; 1994 Aug; 12(10):925-32. PubMed ID: 7975834
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a unique borreliacidal epitope on the outer surface protein C of Borrelia burgdorferi.
Yang X; Li Y; Dunn JJ; Luft BJ
FEMS Immunol Med Microbiol; 2006 Oct; 48(1):64-74. PubMed ID: 16965353
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
[TBL] [Abstract][Full Text] [Related]
17. Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection.
Barthold SW; Levy SA; Fikrig E; Bockenstedt LK; Smith AL
J Am Vet Med Assoc; 1995 Dec; 207(11):1435-40. PubMed ID: 7493871
[TBL] [Abstract][Full Text] [Related]
18. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo.
Zhong W; Wiesmüller KH; Kramer MD; Wallich R; Simon MM
Eur J Immunol; 1996 Nov; 26(11):2749-57. PubMed ID: 8921965
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice.
Bockenstedt LK; Fikrig E; Barthold SW; Flavell RA; Kantor FS
J Immunol; 1996 Dec; 157(12):5496-502. PubMed ID: 8955199
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test.
Callister SM; Schell RF; Case KL; Lovrich SD; Day SP
J Infect Dis; 1993 Jan; 167(1):158-64. PubMed ID: 8418162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
